Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PBMs
PBMs
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Medical Marketing and Media
Wed, 09/20/23 - 08:41 am
PBMs
biosimilars
Humira
PhRMA hits out at PBMs as lurking middlemen in latest ad
Medical Marketing and Media
Tue, 09/5/23 - 08:44 pm
PhRMA
PBMs
lobbying
DTC advertising
Blue Shield of California looks to cut reliance on CVS, taps Amazon
Yahoo/Reuters
Thu, 08/17/23 - 11:30 pm
Blue Shield
insurers
California
CVS Health
PBMs
Amazon
Mark Cuban Cost Plus Drugs
U.S. Appeals Court invalidates significant components of Oklahoma law governing PBMs
Miller & Chevalier
Thu, 08/17/23 - 10:13 am
PBMs
ERISA
Oklahoma
legal
For 2023, Five For-Profit Retailers and PBMs Dominate an Evolving 340B Contract Pharmacy Market
Drug Channels
Tue, 07/11/23 - 10:05 am
340B
drug pricing
CVS Health
Walgreens
Cigna
Express Scripts
Unitedhealth Group
OptumRx
Walmart
PBMs
House lawmakers, PBM lobby spar over committee hearing
BioPharma Dive
Thu, 05/25/23 - 01:11 pm
PBMs
legislation
drug pricing
On heels of Amgen lawsuit, FTC broadens investigation of PBMs
BioPharma Dive
Fri, 05/19/23 - 11:38 am
FTC
PBMs
Ascent Health Services
Zinc Health Services
Senate health committee seeks to rein in drug prices with four new bills
BioSpace
Fri, 05/12/23 - 11:47 am
Senate
drug pricing
generics
PBMs
legislation
What you need to know about pharma, PBM execs testifying on insulin prices
Medical Marketing and Media
Wed, 05/10/23 - 11:15 pm
PBMs
insulin
diabetes
drug pricing
Sanofi
Novo Nordisk
Eli Lilly
Sanders, Cassidy reach deal to increase access to generic prescription drugs, reform PBMs
Fierce Healthcare
Tue, 04/25/23 - 10:13 pm
legislation
PBMs
generics
Senate
Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design
Drug Channels
Tue, 04/4/23 - 10:16 am
drug pricing
generics
PBMs
A sign of what's coming? Presidential hopeful DeSantis targets PBMs and pharma transparency
Endpoints
Mon, 03/20/23 - 04:44 pm
PBMs
transparency
Ron DeSantis
drug pricing
House oversight chair calls for investigation into PBMs' tactics to increase drug costs
Endpoints
Fri, 03/3/23 - 09:59 am
congress
PBMs
PBM trade group ad campaign hits back at drugmakers over prescription drug prices
Medical Marketing and Media
Wed, 02/22/23 - 06:53 pm
PhRMA
PBMs
drug pricing
Senate begins quest to demystify PBMs' practices as it mulls legislation
Endpoints
Thu, 02/16/23 - 08:11 pm
Senate
PBMs
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
Thu, 02/16/23 - 04:49 pm
biosimilars
PBMs
physicians
AbbVie
Humira
Amgen
Amjevita
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Fierce Pharma
Wed, 02/1/23 - 10:22 pm
Novartis
Vas Narasimhan
PhRMA
Inflation Reduction Act
PBMs
small molecule drugs
PBMs likely to be a focus in 118th Congress
Roll Call
Fri, 01/27/23 - 10:54 am
PBMs
congress
drug pricing
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
Drug Channels
Tue, 01/10/23 - 10:44 am
PBMs
Caremark
CVS Health
Express Scripts
Cigna
OptumRx
United Health
formularies
insulin
biosimilars
Humira
Mark Cuban’s drug company teams with first PBM
Medical Marketing and Media
Wed, 09/28/22 - 11:42 am
Mark Cuban
Mark Cuban Cost Plus Drugs
PBMs
Rightway
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »